Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to -$199.9 million.

  • Cellebrite DI's Other Operating Expenses fell 247.26% to -$47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$169.3 million, marking a year-over-year decrease of 233.88%. This contributed to the annual value of -$199.9 million for FY2024, which is 396.77% down from last year.
  • According to the latest figures from FY2024, Cellebrite DI's Other Operating Expenses is -$199.9 million, which was down 396.77% from $67.4 million recorded in FY2023.
  • Cellebrite DI's 5-year Other Operating Expenses high stood at $67.4 million for FY2023, and its period low was -$199.9 million during FY2024.
  • For the 3-year period, Cellebrite DI's Other Operating Expenses averaged around -$25.3 million, with its median value being $56.5 million (2022).
  • As far as peak fluctuations go, Cellebrite DI's Other Operating Expenses skyrocketed by 98.70% in 2022, and later crashed by 396.77% in 2024.
  • Cellebrite DI's Other Operating Expenses (Yearly) stood at $29.2 million in 2020, then fell by 2.46% to $28.5 million in 2021, then soared by 98.70% to $56.5 million in 2022, then grew by 19.17% to $67.4 million in 2023, then slumped by 396.77% to -$199.9 million in 2024.